Back to Journals » Drug Design, Development and Therapy » Volume 12
Review
Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2– advanced breast cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
30,797 | Dovepress* | 19,175+ | 2,770 | 21,945 | |
PubMed Central* | 11,622 | 1,978 | 13,600 | ||
Totals | 30,797 | 4,748 | 35,545 | ||
*Since 16 February 2018 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
7 | 0 | 0 | 0 | 1 | 6 |
View citations on PubMed Central and Google Scholar